Compugen Ltd.
Records under this name other than the patents Compugen Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,098,934 | Polypeptides and Polynucleotides, and Uses Thereof as a Drug Target for Producing Drugs and Biologics Lapsed on the fee record Ended Oct 16, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 16, 2026 | Low confidence |
| US 9,617,336 | C10RF32 Antibodies, and Uses Thereof for Treatment of Cancer Lapsed on the fee record Ended Apr 11, 2025 · High confidence | Lapsed on the fee record | Ended Apr 11, 2025 | High confidence |
| US 8,415,455 | Polypeptides and Polynucleotides, and Uses Thereof as a Drug Target for Producing Drugs and Biologics Lapsed on the fee record Ended Apr 9, 2025 · High confidence | Lapsed on the fee record | Ended Apr 9, 2025 | High confidence |
| US 9,555,087 | Polypeptides and Polynucleotides, and Uses Thereof as a Drug Target for Producing Drugs and Biologics Lapsed on the fee record Ended Jan 31, 2025 · High confidence | Lapsed on the fee record | Ended Jan 31, 2025 | High confidence |
| US 9,428,574 | Polypeptides and uses thereof for treatment of autoimmune disorders and infection Lapsed on the fee record Ended Aug 30, 2024 · From the USPTO record | Lapsed on the fee record | Ended Aug 30, 2024 | From the USPTO record |
| US 9,107,862 | Polypeptides and Polynucleotides, and Uses Thereof as a Drug Target for Producing Drugs and Biologics Lapsed on the fee record Ended Aug 18, 2023 · High confidence | Lapsed on the fee record | Ended Aug 18, 2023 | High confidence |
| US 8,987,191 | Bioactive Peptides and Methods of Using Same Lapsed on the fee record Ended Mar 24, 2023 · High confidence | Lapsed on the fee record | Ended Mar 24, 2023 | High confidence |
| US 7,884,180 | Peptides Which Bind to G Protein-Coupled Receptors Lapsed on the fee record Ended Feb 8, 2023 · High confidence | Lapsed on the fee record | Ended Feb 8, 2023 | High confidence |
| US 8,828,940 | A Method of Treating an Ischemia-Reperfusion Injury-Related Disorder by Administering GPCR ligands Lapsed on the fee record Ended Sep 9, 2022 · High confidence | Lapsed on the fee record | Ended Sep 9, 2022 | High confidence |
| US 7,678,769 | Hepatocyte growth factor receptor splice variants and methods of using same Lapsed on the fee record Ended Mar 16, 2022 · From the USPTO record | Lapsed on the fee record | Ended Mar 16, 2022 | From the USPTO record |